Aaron Saltz - Jul 9, 2021 Form 4 Insider Report for MAGNITE, INC. (MGNI)

Role
General Counsel
Signature
/s/ Aaron Saltz
Stock symbol
MGNI
Transactions as of
Jul 9, 2021
Transactions value $
-$157,575
Form type
4
Date filed
7/13/2021, 05:04 PM
Previous filing
Jun 11, 2021
Next filing
Aug 11, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MGNI Common Stock Options Exercise $6.47K +1.79K +0.67% $3.61 268K Jul 9, 2021 Direct F1
transaction MGNI Common Stock Sale -$137K -4.2K -1.56% $32.66 264K Jul 9, 2021 Direct F1, F2
transaction MGNI Common Stock Sale -$27K -805 -0.31% $33.58 263K Jul 9, 2021 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGNI Stock Option (Right to Buy) Options Exercise $0 -1.79K -3.8% $0.00 45.4K Jul 9, 2021 Common Stock 1.79K $3.61 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This exercise and subsequent sales were made pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.365 to $33.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.48 to $33.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 25% of the total number of shares underlying this option vested on February 14, 2019 and the remaining shares vest 1/36 per month over the next 36 months thereafter, subject to continued service to the Issuer through each vesting date. This equity grant may be subject to accelerated vesting in the event the Reporting Person's employment is terminated under certain circumstances.
F5 Equity grant under the Company's 2014 Equity Incentive Plan.